| CYSB2400240 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400243 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400239 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400238 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2300129 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2023-07-12 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400241 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CXSS2300019 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(3.4) | New Drug Application | 2023-04-19 | | Changchun Lnstitute of Biological Products Co Ltd | | | view |
| CYSB2400242 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB0800073 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2008-11-03 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2009-11-30 | view |
| CXSB0500103 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2006-01-05 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2006-12-30 | view |
| CXSB0800033 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2008-11-03 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2009-12-07 | view |
| CYSB1000216 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2011-02-25 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2013-11-20 | view |
| CYSB1800230 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-10-27 | view |
| CYSB1800229 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-10-27 | view |
| CYSB1000215 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2011-02-25 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2013-11-20 | view |
| CYSB1800228 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-10-27 | view |
| CYSB1000214 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2011-02-25 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2013-11-20 | view |
| CXSR1700003 | 聚乙二醇重组人干扰素α2b注射液 | | Injection | Biological Products | State Standards | 2017-05-03 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2017-09-05 | view |
| CXSL1300096 | 聚乙二醇重组人干扰素α2b注射液 | | Injection | Biological Products(9) | New Drug Application | 2014-04-11 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2017-02-21 | view |
| CXSL1300097 | 聚乙二醇重组人干扰素α2b注射液 | | Injection | Biological Products(9) | New Drug Application | 2014-04-11 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2017-02-21 | view |
